Related Experiment Videos
Hepatocyte growth factor specifically binds to sulfoglycolipids
T Kobayashi1, K Honke, T Miyazaki
1Biochemistry Laboratory, Hokkaido University School of Medicine, Sapporo, Japan.
The Journal of Biological Chemistry
|April 1, 1994
Summary
Hepatocyte growth factor (HGF) binds specifically to sulfoglycolipids, not other lipids. This binding, particularly with SM4, enhances HGF interaction with renal cancer cells, suggesting sulfoglycolipids act as HGF reservoirs.
Area of Science:
- Biochemistry
- Cell Biology
- Glycobiology
Background:
- Hepatocyte growth factor (HGF) is a pleiotropic factor crucial for epithelial cell function.
- HGF's interaction with cell surface molecules is key to its biological activity.
- The role of glycolipids in HGF binding remains incompletely understood.
Purpose of the Study:
- To investigate the interaction between human HGF and various glycolipids.
- To identify specific glycolipid structures that bind HGF.
- To explore the functional implications of HGF-glycolipid interactions in cancer cells.
Main Methods:
- Thin-layer chromatography overlay assays with 125I-HGF.
- Solid-phase binding assays using lipids adsorbed on microtiter plates.
- Glycolipid incorporation into renal cancer cell lines (SMKT-R3) followed by HGF binding assessment.
Main Results:
- HGF selectively bound to sulfoglycolipids (SM4, SM3) but not gangliosides or neutral glycolipids.
- HGF binding to SM4 was inhibited by heparin, dextran sulfate, and fucoidan.
- Incorporation of SM4 into SMKT-R3 cells enhanced HGF binding, while galactosylceramide had no effect.
Conclusions:
- Sulfoglycolipids, particularly SM4, are direct binding partners for HGF.
- Endogenous sulfoglycolipids on renal cancer cells may serve as reservoirs for HGF.
- These findings highlight a novel mechanism for HGF regulation and signaling in cancer.